SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 49 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $23,000 | -4.2% | 10,026 | -1.2% | 0.00% | – |
| Q4 2018 | $24,000 | -84.2% | 10,150 | -0.8% | 0.00% | -100.0% |
| Q3 2018 | $152,000 | -0.7% | 10,229 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $153,000 | -15.5% | 10,045 | +4.1% | 0.00% | 0.0% |
| Q1 2018 | $181,000 | +191.9% | 9,654 | +184.6% | 0.00% | – |
| Q4 2017 | $62,000 | -15.1% | 3,392 | +3.9% | 0.00% | – |
| Q3 2017 | $73,000 | – | 3,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Wealth Management, LLC | 180,552 | $36,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 122,942 | $24,000 | 0.00% |
| CITIGROUP INC | 1,739 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 52,553 | $11,000 | 0.00% |
| MORGAN STANLEY | 101 | $0 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 15,936 | $3,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 20 | $0 | 0.00% |
| BlackRock Inc. | 90,036 | $18,000 | 0.00% |
| Ballentine Partners, LLC | 16,700 | $3,000 | 0.00% |
| Citadel Advisors | 83,839 | $17,000 | 0.00% |